Form 4: Colgate-Palmolive CFO Receives Equity Awards

Colgate-Palmolive's Chief Financial Officer, Stanley J. Sutula III, was granted 8,328 restricted stock units and 57,661 stock options as part of the company's incentive compensation plan.

Summary

• Stanley J. Sutula III, Chief Financial Officer of Colgate-Palmolive Co., was granted 8,328 shares of Common Stock as restricted stock units (RSUs) on September 11, 2025.
• The RSUs were granted at a price of $0.0000 per share and will vest in equal 1/3 installments on the first, second, and third anniversaries of the grant date.
• Additionally, Mr. Sutula was granted 57,661 stock options on September 11, 2025, with an exercise price of $84.06 per share.
• These stock options become exercisable in equal annual installments over three years, beginning on the first anniversary of the September 11, 2025 grant date, and expire on September 11, 2033.
• Following these transactions, Mr. Sutula directly beneficially owns 57,732 shares of Common Stock and 57,661 stock options.
• An additional 324 shares of Common Stock are indirectly beneficially owned by Mr. Sutula through the Issuer's 401(k) Plan Trustee.

Sentiment

Score: 7

Explanation: The filing reports a routine equity grant to a key executive, which is a positive for management alignment and retention but does not indicate a significant change in the company's fundamental outlook or operations.

Positives

• The grant of restricted stock units and stock options aligns the Chief Financial Officer's interests with those of shareholders, incentivizing long-term performance.
• Equity awards are a standard component of executive compensation, indicating a commitment to retaining key management personnel.

Future Outlook

The equity awards, with their multi-year vesting and exercisability schedules, are designed to incentivize the Chief Financial Officer's continued long-term commitment and performance, aligning future efforts with shareholder value creation.

Industry Context

The grant of restricted stock units and stock options to a senior executive like the CFO is a common practice in the consumer staples industry and across publicly traded companies. It serves as a key component of executive compensation packages, aiming to attract, retain, and motivate top talent by linking their personal wealth to the company's stock performance.

Comparison to Industry Standards

• The structure of these equity grants, including multi-year vesting for RSUs and exercisability for options, is consistent with typical executive compensation practices observed in large-cap consumer goods companies such as Procter & Gamble (PG), Unilever (UL), and Kimberly-Clark (KMB).
• The use of both restricted stock units and stock options provides a balanced incentive, offering both retention value (RSUs) and performance-based upside potential (options), a common strategy among industry peers.

Corporate Governance

Stakeholder Impact

• Shareholders: The equity grants align the Chief Financial Officer's financial interests with shareholder value creation, potentially leading to more focused long-term strategic decisions.
• Employees: The compensation structure for senior management can influence overall company culture and compensation philosophy, potentially impacting employee morale and retention strategies.

Next Steps

• The restricted stock units will vest in equal 1/3 installments on the first, second, and third anniversaries of the September 11, 2025 grant date.
• The stock options will become exercisable in equal annual installments over three years, beginning on the first anniversary of the September 11, 2025 grant date.

Key Dates

Recommendation

This Form 4 filing details a routine equity compensation grant to a senior executive. While positive for management alignment, it does not provide new fundamental information about the company's financial performance, strategic direction, or market position that would warrant a change in an existing investment recommendation.

Keywords

Colgate-Palmolive, CL, Stanley J. Sutula III, CFO, Form 4, Equity Awards, Restricted Stock Units, Stock Options, Insider Transaction, Executive Compensation